Directory Calendar News Careers Alumni Giving

HPM Department News

Meet HPM's Lauren Borrelli, Korean Foreign Language and Area Studies Fellowship Winner

HPM's LAUREN BORRELLI plans to utilize her fellowship to build industry-specific knowledge of the Korean health care market. As a Korean-American, she is excited to be able to connect her cultural heritage to her professional career.   

Gellad tells Nightly Business Report about impact of new California bill (Video)

image
CNBC - New California legislation prompts Nightly Business Report ’s Meg Tirrell to ask HPM’s WALLID GELLAD about California Governor Brown’s bill requiring pharma to announce 60 days before a rise of more than 16 percent over two years, and to provide justification for the hike. Locate Gellad’s comments at 17:37–18:05. 

Gellad interviewed on Cigna's new OxyContin Rx policy

image
CNN - Despite any advantages Xtampza may have (harder to crush and abuse), “people still get addicted to oral pills. They can still take too much. They can still overdose,” said HPM’s WALLID GELLAD, co-director of the University of Pittsburgh’s Center for Pharmaceutical Policy and Prescribing. Gellad believes that there'’s more to Cigna’s new policies than a desire to combat the opioid crisis. 

HPM alumni get together in DC

image
Some of our favorite HPM alumni connected at Clyde’s of Gallery Place on September 27, 2017. Back Row: Jenny Huang, Alexandra Dulin, Alex Nason, David Tye, Mark Faccenda, Kevin Broom, Mark Roberts; Front Row: Deborah Backman, Nikita Sharma, Sally Caine Leathers, Kelly Delmore, Kristin Lazzara, and Kush Banjeree. 

Hernandez on outcomes-based pricing for PCSK9 inhibitors

image
AMERICAN JOURNAL OF MANAGED CARE - An article by alumna INMACULADA (INMA) HERNANDEZ (HPM ’16) discusses the impact of the outcomes-based pricing arrangements proposed by Amgen on the pricing of PCSK9 inhibitor therapy, and provides recommendations for payers on the design of outcomes-based contracts. She is an assistant professor at Pitt’s School of Pharmacy. Her research explores the intersection of pharmaceutical health services and outcomes re... 

Gellad questions CVS Health move to limit access to opioid painkillers

image
WALL STREET JOURNAL - One of the largest managers of pharmaceutical benefits in the U.S. says it will start limiting the duration and dose of some prescriptions for opioid painkillers, in an effort to combat widespread addiction. The restrictions, based on CDC recommendations published last year, could cause some debate. WALID GELLAD, physician and HPM assistant professor, said the restrictions for chronic pain could cause cumbersome paperwork an... 

Carolinas HealthCare System names DeFurio as new CFO

image
CHARLOTTE BUSINESS JOURNAL - After a natioinwide search, NC-based Carolinas HealthCare System has tapped alumnus ANTHONY DEFURIO (HADM ’89) to serve as executive vice president and CFO, effective October 2017. Carolinas recently announced it would merge with Chapel Hill-based UNC Health Care, forming one of the nation’s largest hospital networks. Leading up to this new position, DeFurio was senior vice president and CFO at University of Colorado ... 

Gellad says the naloxone pricing system is out of control (video)

image
WTAE ACTION NEWS - As the opioid crisis sweeping the country, demand for naloxone has soared—and so has the price. HPM’s WALID GELLAD, who studies drug pricing, says the system is completely out of control. Naloxone cost increases have sky-rocketed, a huge concern for emergency service providers and community organizations. 

Gellad sceptical that drug company outcomes-based pricing can lower costs

image
Drug policy researcher WALID GELLAD says the outcomes-based contracts are being viewed as the solution to the drug-price problem, and they’re not going to be, at least not in the short term. The deals don’t stop drug companies from charging high starting prices for new drugs or from steadily raising prices for older drugs. Any rebates or discounts in outcomes-based contracts are off an already inflated number. He favors other ways to curb drug co... 

Accreditation president visits HPM to learn more about MHA program

image
Anthony Stanowski, president and CEO of the Commission of Accreditation of Healthcare Management Education (CAHME), visited the Department of Health Policy and Management on Wednesday, August 30. His main goals of the visit were to learn more about our MHA program and to stress the importance of CAHME accreditation in advancing the quality of health care management education. 

Meet Chandler Caufield (HPM '20), Dean's Scholar

image
Pittsburgh native and MHA/MBA student CHANDLER CAUFIELD (HPM ’20) was familiar with the city’s burgeoning medical sector buoyed by world-class hospitals and universities; however, it wasn’t until she worked in the industry that she discovered health care was the field for her. "Eventually, I landed on health care administration because it seemed like the perfect intersection of my interests and skills as well as my passion for improving the pati... 

Gellad on the cancer drug pricing firestorm

image
AXIOS - Doctor and health policy professor WALID GELLAD said the real question is why a potential breakthrough drug that has some question marks about effectiveness should cost more than proven life-saving measures like bone marrow or kidney transplants. “This is an amazing therapy, but there has to be a limit at which point companies can no longer charge desperate patients, or taxpayers, enormous sums.” 

Shapiro interviewed about growing better, not bigger

image
BECKER’S HOSPITAL REVIEW - Pitt Public Health alumnus LOU SHAPIRO (HPM ’84), CEO of the New York based Hospital for Special Surgery, talks about how he plans to stay competitive in an increasingly consolidated healthcare landscape and what it means to grow better instead of bigger. 

Hernandez says evolocumab not cost-effective at current price

image
TCTMD - Two new analyses call into question the cost-effectiveness of adding the PCSK9 inhibitor evolocumab to statin therapy in patients with atherosclerotic cardiovascular disease. Pitt Public Health alumna INMACULADA HERNANDEZ (HPM ’16) noted that the conclusions of the two papers are the same: the drug’s cost “is way above what we usually considered cost-effective in this country.” 

Donohue's research says hospitals could do more for survivors of opioid overdoses

image
NPR - Using claims data from Medicaid patients in Pennsylvania from 2008 to 2013, HPM’s JULIE DONOHUE looked at prescription opioid use and medication-assisted treatment rates before and after overdoses. The study's senior author found that “This is a time when people are vulnerable, potentially frightened by this event that’s just occurred and amenable to advice, referral, and treatment recommendations. It’s safe to characterize it as a missed o... 

Page 7 of 21First   Previous   2  3  4  5  6  [7]  8  9  10  11  Next   Last   

Search for an Article

Share Your News

Simply click to share news of your achievements -- and those of classmates or colleagues. We're eager to hear about and share stories of student, faculty, and alumni accomplishments. Email questions to phcomm@pitt.edu or visit publichealth.pitt.edu/sharenews.

© 2018 by University of Pittsburgh Graduate School of Public Health

Login  |  Sitemap